Makers Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 878419, "name": "Makers Labs.", "stock_name": "Makers Labs.", "full_name": "Makers Laboratories Ltd", "name_url": "stocks-analysis/makers-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "149.80", "chg": -0.1, "chgp": "-0.07%", "dir": -1, "prev_price": "149.90", "mcapval": "91.00 Cr", "mcap": "Micro Cap", "scripcode": 506919, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE987A01010", "curr_date": "Jul 17, 03:30 PM", "curr_time": "08:52 AM", "last_traded_at": "Jul 17, 03:30 PM IST", "bse_nse_vol": "805 ", "exc_status": "Active", "traded_date": "Jul 17, 2026", "traded_date_str": "2026 07 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/makers-labs-878419-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Makers Laboratories Ltd Gains 1.05%: Downgrade and Valuation Shift Shape Weekly Moves", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-gains-105-downgrade-and-valuation-shift-shape-weekly-moves-4107398", "imagepath": "", "date": "2026-07-18 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens at Rs.152.60, gaining 2.93% on the day</p>\n <p><strong>14 Jul:</strong> Mojo grade downgraded to Sell amid valuation concerns</p>\n <p><strong>15 Jul:</strong> Valuation grade shifts from attractive to fair</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.149.80, up 1.05% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.152.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.149.80</di..." }, { "title": "Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-sell-amid-valuation-and-financial-concerns-4103246", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4103246.png", "date": "2026-07-15 08:11:14", "description": "Makers Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including valuation, financial trends, quality, and technical indicators. Despite some positive quarterly results, concerns over long-term profitability and valuation metrics have prompted this change, signalling caution for investors in the pharmaceuticals sector." }, { "title": "Makers Laboratories Ltd Valuation Shifts Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-amid-sector-dynamics-4102945", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_valuationdot_4102945.png", "date": "2026-07-15 08:00:58", "description": "Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging Pharmaceuticals & Biotechnology sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks." }, { "title": "Makers Laboratories Ltd Upgraded to Hold on Improved Valuation and Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-upgraded-to-hold-on-improved-valuation-and-financial-trends-4091688", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_mojoScore_4091688.png", "date": "2026-07-07 08:30:17", "description": "Makers Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and positive financial trends. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts." }, { "title": "Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-from-attractive-to-fair-amidst-sector-dynamics-4089887", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MakersLaborator_valuationdot_4089887.png", "date": "2026-07-06 08:01:15", "description": "Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of late June 2026. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, set against a backdrop of sector-wide valuation trends and company-specific performance metrics." }, { "title": "Makers Laboratories Ltd Declines 0.95%: Valuation and Profitability Concerns Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-declines-095-valuation-and-profitability-concerns-weigh-4088794", "imagepath": "", "date": "2026-07-04 15:01:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Jun:</strong> Valuation shifts from attractive to fair</p>\n <p><strong>30 Jun:</strong> Downgrade to Sell rating announced</p>\n <p><strong>2 Jul:</strong> Sharp 8.05% price jump amid sector gains</p>\n <p><strong>3 Jul:</strong> Price retreats 5.96% to close the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.152.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.151.45</div><div class=\"stat-change negative\">-0.95%</di..." }, { "title": "Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/makers-laboratories-ltd-downgraded-to-sell-amid-valuation-and-financial-concerns-4078167", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MakersLaborator_mojoScore_4078167.png", "date": "2026-06-30 08:22:55", "description": "Makers Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 29 June 2026. The revision reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals, with valuation concerns playing a pivotal role in the downgrade despite some positive quarterly performance." }, { "title": "Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-valuation-shifts-from-attractive-to-fair-amid-sector-dynamics-4076299", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MakersLaborator_valuationdot_4076299.png", "date": "2026-06-29 08:00:59", "description": "Makers Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions amid a competitive pharmaceutical sector. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s current price attractiveness." }, { "title": "Makers Laboratories Ltd Falls 2.42%: Valuation Upgrade and Mixed Financials Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/makers-laboratories-ltd-falls-242-valuation-upgrade-and-mixed-financials-shape-week-4075346", "imagepath": "", "date": "2026-06-27 15:00:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>22 Jun:</strong> Stock opened at Rs.147.80, down 2.09% amid valuation upgrade</p>\n <p><strong>23 Jun:</strong> MarketsMOJO upgraded Makers Laboratories Ltd to Hold on improved valuation and financial trends</p>\n <p><strong>24 Jun:</strong> Stock rebounded with a 1.85% gain to Rs.145.90</p>\n <p><strong>25 Jun:</strong> Week closed at Rs.147.30, down 0.31% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.150.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">W..." } ], "total": 140, "sid": "878419", "stock_news_url": "https://www.marketsmojo.com/news/makers-laboratories-878419" }, "announcements": [ { "caption": "Intimation To Shareholders Regarding Weblink Of Annual Report", "datetime": "13-Jul-2026", "details": "Intimation to shareholders regarding weblink of Annual Report", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "13-Jul-2026", "details": "Copy of Newspaper Publication", "source": "BSE" }, { "caption": "Reg. 34 (1) Annual Report.", "datetime": "10-Jul-2026", "details": "Annual Report 2025-26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Makers Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 01 Aug 19", "dt": "2019-08-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Makers Laboratories Ltd has announced <strong>1:5</strong> rights issue, ex-date: 30 Mar 22", "dt": "2022-03-30", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

13 Jul: Stock opens at Rs.152.60, gaining 2.93% on the day

14 Jul: Mojo grade downgraded to Sell amid valuation concerns

15 Jul: Valuation grade shifts from attractive to fair

17 Jul: Week closes at Rs.149.80, up 1.05% for the week

Week Open

Rs.152.60

Week Close

Rs.149.80Read full news article

Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns

2026-07-15 08:11:14

Makers Laboratories Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including valuation, financial trends, quality, and technical indicators. Despite some positive quarterly results, concerns over long-term profitability and valuation metrics have prompted this change, signalling caution for investors in the pharmaceuticals sector.

Read full news article

Makers Laboratories Ltd Valuation Shifts Amid Sector Dynamics

2026-07-15 08:00:58

Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging Pharmaceuticals & Biotechnology sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks.

Read full news article

Makers Laboratories Ltd Upgraded to Hold on Improved Valuation and Financial Trends

2026-07-07 08:30:17

Makers Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved valuation profile and positive financial trends. The micro-cap pharmaceutical company’s recent performance and comparative metrics have prompted a reassessment of its quality, valuation, financial trend, and technical outlook, culminating in a more favourable stance by analysts.

Read full news article

Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amidst Sector Dynamics

2026-07-06 08:01:15

Makers Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade as of late June 2026. This change reflects evolving market perceptions amid fluctuating price-to-earnings (P/E) and price-to-book value (P/BV) ratios, set against a backdrop of sector-wide valuation trends and company-specific performance metrics.

Read full news article

Makers Laboratories Ltd Declines 0.95%: Valuation and Profitability Concerns Weigh

2026-07-04 15:01:51

Key Events This Week

29 Jun: Valuation shifts from attractive to fair

30 Jun: Downgrade to Sell rating announced

2 Jul: Sharp 8.05% price jump amid sector gains

3 Jul: Price retreats 5.96% to close the week

-0.95%Read full news article

Makers Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns

2026-06-30 08:22:55

Makers Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 29 June 2026. The revision reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals, with valuation concerns playing a pivotal role in the downgrade despite some positive quarterly performance.

Read full news article

Makers Laboratories Ltd Valuation Shifts: From Attractive to Fair Amid Sector Dynamics

2026-06-29 08:00:59

Makers Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions amid a competitive pharmaceutical sector. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s current price attractiveness.